MARCY COVERT: Open Payments
NPI 1992464325 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 57 payments from 19 companies in 2025. Trend: 2023 $761 · 2024 $593 · 2025 $1,063
Food & beverage: $1,028Education: $35
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 19 | $302 |
| PFIZER INC. | 6 | $112 |
| UROGEN PHARMA, INC. | 4 | $107 |
| ABBVIE INC. | 4 | $69 |
| Endo USA, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Teleflex LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
Products named: GEMTESA, XTANDI, ORGOVYX, XIAFLEX, BOTOX, BARRIGEL, JOURNAVX, ADSTILADRIN.
Industry payments across IA — which companies pay providers there.
